annual CFO:
-$166.31M-$85.14M(-104.89%)Summary
- As of today (September 16, 2025), MLYS annual cash flow from operations is -$166.31 million, with the most recent change of -$85.14 million (-104.89%) on December 31, 2024.
- During the last 3 years, MLYS annual CFO has fallen by -$151.75 million (-1042.34%).
- MLYS annual CFO is now -6652.50% below its all-time high of -$2.46 million, reached on December 1, 2020.
Performance
MLYS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$30.17M+$15.32M(+33.68%)Summary
- As of today (September 16, 2025), MLYS quarterly cash flow from operations is -$30.17 million, with the most recent change of +$15.32 million (+33.68%) on June 30, 2025.
- Over the past year, MLYS quarterly CFO has dropped by -$23.00 thousand (-0.08%).
- MLYS quarterly CFO is now -451.64% below its all-time high of -$5.47 million, reached on June 1, 2022.
Performance
MLYS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$192.69M-$23.00K(-0.01%)Summary
- As of today (September 16, 2025), MLYS TTM cash flow from operations is -$192.69 million, with the most recent change of -$23.00 thousand (-0.01%) on June 30, 2025.
- Over the past year, MLYS TTM CFO has dropped by -$95.39 million (-98.04%).
- MLYS TTM CFO is now -3423.22% below its all-time high of -$5.47 million, reached on June 1, 2022.
Performance
MLYS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MLYS Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -104.9% | -0.1% | -98.0% |
| 3 y3 years | -1042.3% | -451.6% | -3423.2% |
| 5 y5 years | -6652.5% | - | - |
MLYS Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1042.3% | at low | -451.6% | +54.9% | -3423.2% | at low |
| 5 y | 5-year | -6652.5% | at low | -451.6% | +54.9% | -3423.2% | at low |
| alltime | all time | -6652.5% | at low | -451.6% | +54.9% | -3423.2% | at low |
MLYS Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$30.17M(-33.7%) | -$192.69M(+0.0%) |
| Mar 2025 | - | -$45.49M(-31.9%) | -$192.66M(+15.8%) |
| Dec 2024 | -$166.31M(+104.9%) | -$66.84M(+33.2%) | -$166.31M(+29.5%) |
| Sep 2024 | - | -$50.19M(+66.5%) | -$128.45M(+32.0%) |
| Jun 2024 | - | -$30.15M(+57.5%) | -$97.30M(+11.1%) |
| Mar 2024 | - | -$19.14M(-34.0%) | -$87.54M(+7.8%) |
| Dec 2023 | -$81.17M | -$28.98M(+52.3%) | -$81.17M(+30.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$19.03M(-6.6%) | -$62.38M(+23.9%) |
| Jun 2023 | - | -$20.39M(+59.6%) | -$50.34M(+42.1%) |
| Mar 2023 | - | -$12.78M(+25.4%) | -$35.42M(+56.4%) |
| Dec 2022 | -$29.22M(+100.7%) | -$10.19M(+45.8%) | -$22.64M(+81.8%) |
| Sep 2022 | - | -$6.99M(+27.8%) | -$12.46M(+127.8%) |
| Jun 2022 | - | -$5.47M | -$5.47M |
| Dec 2021 | -$14.56M(+491.1%) | - | - |
| Dec 2020 | -$2.46M | - | - |
FAQ
- What is Mineralys Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. annual CFO year-on-year change?
- What is Mineralys Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Mineralys Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Mineralys Therapeutics, Inc.?
- What is Mineralys Therapeutics, Inc. TTM CFO year-on-year change?
What is Mineralys Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of MLYS is -$166.31M
What is the all time high annual CFO for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high annual cash flow from operations is -$2.46M
What is Mineralys Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, MLYS annual cash flow from operations has changed by -$85.14M (-104.89%)
What is Mineralys Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of MLYS is -$30.17M
What is the all time high quarterly CFO for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high quarterly cash flow from operations is -$5.47M
What is Mineralys Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, MLYS quarterly cash flow from operations has changed by -$23.00K (-0.08%)
What is Mineralys Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of MLYS is -$192.69M
What is the all time high TTM CFO for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high TTM cash flow from operations is -$5.47M
What is Mineralys Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, MLYS TTM cash flow from operations has changed by -$95.39M (-98.04%)